| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/05/2005 | CN1678347A Antibodies and uses thereof |
| 10/05/2005 | CN1221565C Peptides and their derivatives thereof showing cell attachment, spreading and detachment activity |
| 10/04/2005 | US6951916 Melanocortin receptor ligands |
| 10/04/2005 | US6951915 Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use |
| 10/04/2005 | US6951745 Polyhydroxyalkanoate-containing structure and manufacturing method thereof |
| 10/04/2005 | US6951717 Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission |
| 10/04/2005 | CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g |
| 10/02/2005 | CA2461375A1 Cea binding agents compositions to reverse cea-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof |
| 09/29/2005 | WO2005090995A2 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility |
| 09/29/2005 | WO2005090579A1 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 09/29/2005 | WO2005090570A1 Therapeutic compositions and methods for treating diseases that involve angiogenesis |
| 09/29/2005 | WO2005090389A2 Isosteric transformation |
| 09/29/2005 | WO2005090388A1 Alpha helical mimics, their uses and methods for their production |
| 09/29/2005 | WO2005090387A2 Histone h2a peptide derivatives and analogs and methods of use thereof |
| 09/29/2005 | WO2005090386A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 09/29/2005 | WO2005012329A3 Kinase and phosphatase assays |
| 09/29/2005 | US20050215528 Gnrh agonist combination drugs |
| 09/29/2005 | US20050215486 Peptidomimetic compounds, useful as antiviral agents |
| 09/29/2005 | US20050215483 Peptide inhibitors of protein kinase c |
| 09/29/2005 | US20050215482 Modulating cell adhesion, cancer cell adhesion, cancer cell invasion, cancer metastasis, bone turnover and remodeling, VEGF synthesis, TGF-beta synthesis |
| 09/29/2005 | US20050215481 Antimicrobial peptide, its analogs and antimicrobial composition comprising them |
| 09/29/2005 | US20050215478 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 09/29/2005 | US20050215470 peptides and/or conjugated peptides may be used as therapeutics or prophylactics for the treatment of diseases mediated by B1 activation, including inflammation and chronic pain states of inflammatory and neuropathic origin, septic shock, arthritis, osteoarthritis, angina, asthma, allergic rhinitis |
| 09/29/2005 | US20050215467 Multimeric Apo A-I agonist compounds |
| 09/29/2005 | US20050214943 Transcription factors; nuclear localization peptides; signal sequences; NF-kappaB/Rel proteins; modulating expression of a gene |
| 09/29/2005 | US20050214878 Method for the diagnosis of cancer by measuring the changes of glycosylation of proteins related to tumorgenesis and metastasis and kit for diagnosis of cancers using the same |
| 09/29/2005 | US20050214859 Hepatocyte growth factor (HGF) receptor complex for identifying modulator for prevention and treatment of cell proliferative disorders |
| 09/29/2005 | US20050214852 Peptides for the treatment and diagnosis of systemic lupus erythematosus |
| 09/29/2005 | US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
| 09/29/2005 | US20050214300 Methods for treating cancer using Porimin as a target |
| 09/29/2005 | US20050214295 Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shock |
| 09/29/2005 | CA2562133A1 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
| 09/29/2005 | CA2559215A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 09/28/2005 | EP1580273A1 Peptide-based method for monitoring gene expression in a host cell |
| 09/28/2005 | EP1579218A2 Method of modulation of interaction between receptor and ligand |
| 09/28/2005 | EP1578993A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 09/28/2005 | EP1578928A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 09/28/2005 | EP1578787A1 Novel chi-conotoxin peptides (-ii) |
| 09/28/2005 | EP1578785A1 Peptides that bind to the heparin binding domain of vegf and vegfr-2 |
| 09/28/2005 | EP1578784A2 Peptides that bind to the vegfr-2 |
| 09/28/2005 | EP1578769A2 Peptides and the use thereof in darkening the skin |
| 09/28/2005 | EP1439849A4 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 09/28/2005 | EP0767835B1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 09/28/2005 | EP0743955B1 Cyclic nerve growth factor (ngf) structural analogs and their uses |
| 09/28/2005 | CN1675542A Isolation and identification of T cells |
| 09/28/2005 | CN1675362A HLA-A24-restricted cancer antigen peptide |
| 09/28/2005 | CN1674927A Growth hormone releasing peptides |
| 09/28/2005 | CN1220700C Staphylococcus aureus virulence stimulating factor inhibiting peptide and its application |
| 09/28/2005 | CN1220699C Polypeptide for inhibiting growth and migration of blood vessel endothelial cell and endothelial stem cell and its preparing method and use |
| 09/27/2005 | US6949681 Intermediate for preparing glycopeptide derivatives |
| 09/27/2005 | US6949515 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases |
| 09/27/2005 | US6949365 Gonadotropin-releasing hormone (GnRH-III); for controlling the gonadal development and spawning, maturation, and reproduction of fish |
| 09/27/2005 | US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF |
| 09/27/2005 | US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections |
| 09/22/2005 | WO2005087798A1 D-ser!8-cyclosporine modified on the hydroxyl group having a switchable inhibiting effect on protein phosphatase calcineurine and specific manipulipulatability obtained therewith of the immunosuppressive effect while maintaining inhibition of peptidyl-prolyl-cis-trans-isomerase (ppi) e.g. for the treatment of autoimmune d |
| 09/22/2005 | WO2005087797A1 Methods and compositions for the treatment of gastrointestinal disorders |
| 09/22/2005 | WO2005087796A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof |
| 09/22/2005 | WO2005087795A1 Use of peptides as penetrating cell carriers |
| 09/22/2005 | WO2005087794A1 Process for octreotide synthesis |
| 09/22/2005 | WO2005087793A2 Immunostimulatory compositions and uses thereof |
| 09/22/2005 | WO2005087792A2 Materials and methods relating to the treatment of glioblastomas |
| 09/22/2005 | WO2005087731A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 09/22/2005 | WO2005087261A2 Identification of self and non-self antigens implicated in autoimmune diseases |
| 09/22/2005 | WO2005030258A3 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 09/22/2005 | WO2005016248A3 A novel antiproliferative factor and methods of use |
| 09/22/2005 | WO2005014624A3 Preparation of somatostatin peptides |
| 09/22/2005 | WO2005007069A3 Soft gel formulations for saquinavir |
| 09/22/2005 | WO2004101606A3 Novel peptides that bind to the erythropoietin receptor |
| 09/22/2005 | WO2003065997A3 Anti-infarction molecules |
| 09/22/2005 | US20050209161 Drugs for treatment of inflammation/blood brain barrier degradation;administering to a subject in need of such treatment, a pharmaceutically effective amount of a peptide antagonist of zonulin, wherein the peptide antagonist binds to a zonula occludens toxin receptor |
| 09/22/2005 | US20050209159 Effectors of dipeptidyl peptidase IV for topical use |
| 09/22/2005 | US20050209158 Inhibitors of the ATPase activity of Hsp90; antitumor drugs |
| 09/22/2005 | US20050209156 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 09/22/2005 | US20050209146 Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy |
| 09/22/2005 | US20050209145 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 09/22/2005 | US20050208678 Using capillary electrophoresis and laser induced fluorescent detection to monitor protein complex formation between membrane glycoproteins and helical polypeptides |
| 09/22/2005 | US20050208635 Synthesizing on base material polyhydroxyalkanoate using 3-hydroxyacyl coenzyme A as substrate; color filters; static charge image developing toner; electrophoresis; inks |
| 09/22/2005 | US20050208626 SGIP peptides |
| 09/22/2005 | US20050208594 Using early secretory antigenic target-6 protein (ESAT-6) as tool in identifying individuals with mycobacterium infection; immunodiagnostics |
| 09/22/2005 | US20050208589 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 09/22/2005 | US20050208537 Very large scale immobilized polymer synthesis |
| 09/22/2005 | US20050208140 A di, tri or oligopeptide covalently bonded with an active agent ( therapeutical agent, contrast agent or fluorescent dye) from a side chain of the intermediate or C-terminus amino acid |
| 09/22/2005 | US20050208064 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/22/2005 | US20050208055 Monoclonal antibodies; hybridoma cell lines; for use in Western blot analysis, immunohistochemisty, protein purification; diagnosis of cancer and vitamin D metabolic conditions; drug screening |
| 09/22/2005 | US20050208039 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 09/22/2005 | DE102004011988A1 Cyclosporinderivate und diese enthaltende pharmazeutische Zusammensetzungen Cyclosporin derivatives and pharmaceutical compositions containing them |
| 09/22/2005 | CA2559887A1 Method for inhibiting immune complex formation in a subject |
| 09/22/2005 | CA2559124A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof |
| 09/22/2005 | CA2559065A1 Identification of self and non-self antigens implicated in autoimmune diseases |
| 09/22/2005 | CA2558050A1 Methods and compositions for the treatment of gastrointestinal disorders |
| 09/22/2005 | CA2557495A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 09/21/2005 | EP1577320A1 Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 09/21/2005 | EP1576350A2 Peptides for detection of antibody to a. phagocytophila |
| 09/21/2005 | EP1576126A2 Systems for capture and analysis of biological particles and methods using the systems |
| 09/21/2005 | EP1576001A2 Endothelial cell specifically binding peptides |
| 09/21/2005 | EP1576000A2 Process for the preparation of bicyclic hexa-peptide nepadutant |
| 09/21/2005 | EP1575991A2 Peptides comprising aromatic d-amino acids and methods of use |
| 09/21/2005 | EP1575987A2 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 09/21/2005 | EP1575602A2 Methods for treating cancer using porimin as a target |
| 09/21/2005 | EP1575525A2 Cell surface tropomyosin as a target of angiogenesis inhibition |